<i>Methods</i>: A search of the literature showed a marked development of experimental studies exploring the molecular pathogenesis of AML with <i>KMT2A-r</i> and of clinical studies evaluating new induction intensive treatments and the development of a targeted therapy based on Menin inhibitors. This evidence concerns the gene MEN1 and acute myeloid leukemia.